The Bellcast
Bridge the investing and markets knowledge gap with the Bell Direct Bellcast. From bite-size thought snippets, to full length interviews with the top executives of leading ASX200 companies, you'll be informed and ready for any market movement.
Podcasting since 2020 • 86 episodes
The Bellcast
Latest Episodes
From the helm: Blackpearl Group Limited (ASX:BPG), Nick Lissette, CEO
In this episode of From the helm, Sophia Mavridis chats with Blackpearl Group’s Chief Executive Officer, Nick Lissette to discuss the rapid evolution of AI-powered sales and marketing tools, and how enterprise adoption is set to accelerate as m...
•
16:41
From the Helm: Rural Funds Group (ASX:RFF), Tim Sheridan, COO & James Powell, GM
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed a...
•
13:43
From the helm: SenSen Networks Limited (ASX: SNS), Dr Subhash Challa, CEO
In this episode of From the Helm, Grady Wulff sits down with SenSen Networks Limited (ASX:SNS) CEO, Dr Subhash Challa, to discuss the company’s strong FY25 performance, growing profitability, and strategic roadmap amid the global AI and sensor ...
•
18:58
From the helm: Bhagwan Marine Limited (ASX:BWN), Andrew Wackett, Director of Finance
In this episode of from the helm, Grady Wulff sits down with Bhagwan Marine Limited (ASX:BWN) Director of Finance, Andrew Wackett, to unpack the company’s record FY25 results, divisional growth opportunities, and strategic plans for FY26 and be...
•
8:15
From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD
Join Bell Financial Group's Senior Market Analyst Grady Wulff as she sat down with Dr. Liz Dallimore, CEO & MD of Argenica Therapeutics (ASX:AGN) to discuss the company's lead drug candidate ARG-007, and its pathway to commercialisation to ...
•
11:42